What is the recommended inhaled salbutamol (albuterol) dosage for adults, adolescents, and children?

Salbutamol (Albuterol) Inhaled Dosage

For acute asthma exacerbations, adults should receive 2.5-5 mg via nebulizer or 4-8 puffs via MDI every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed; children should receive 0.15 mg/kg (minimum 2.5 mg) via nebulizer or 4-8 puffs via MDI every 20 minutes for 3 doses, then 0.15-0.3 mg/kg every 1-4 hours as needed. 1

Acute Exacerbation Dosing

Initial Treatment (First Hour)

Adults:

• Nebulizer: 2.5-5 mg every 20 minutes for 3 doses 1, 2
• MDI (90 mcg/puff): 4-8 puffs every 20 minutes for 3 doses 1, 2
• MDI with valved holding chamber (VHC) is equally effective as nebulizer in mild-to-moderate exacerbations with proper technique 1

Children (≥4 years):

• Nebulizer: 0.15 mg/kg (minimum dose 2.5 mg) every 20 minutes for 3 doses 1, 2
• MDI (90 mcg/puff): 4-8 puffs every 20 minutes for 3 doses 1, 2

Subsequent Dosing (After Initial 3 Doses)

Adults:

• Intermittent: 2.5-10 mg every 1-4 hours as needed via nebulizer 1
• Continuous nebulization: 10-15 mg/hour for severe exacerbations 1
• MDI: 4-8 puffs every 1-4 hours as needed 1

Children:

• Intermittent: 0.15-0.3 mg/kg (up to 10 mg) every 1-4 hours as needed 1
• Continuous nebulization: 0.5 mg/kg/hour for severe exacerbations 1
• MDI: 4-8 puffs every 1-4 hours as needed 1

Maintenance/Prevention Dosing

Adults and children ≥4 years:

• Routine bronchodilation: 2 inhalations (180 mcg) every 4-6 hours 3
• Exercise-induced bronchospasm: 2 inhalations 15-30 minutes before exercise 3
• Some patients may require only 1 inhalation every 4 hours 3

Critical Implementation Points

Delivery Method Selection

• MDI with spacer is preferred over nebulizer for mild-to-moderate exacerbations when proper technique is ensured 1, 4
• Recent evidence shows MDI results in fewer hospitalizations, shorter emergency department visits, and fewer side effects compared to nebulization, particularly in children under 6 years 4
• Nebulizers require dilution to minimum 3 mL at gas flow 6-8 L/min for optimal delivery 1, 2

Age-Specific Considerations

Children under 2 years:

• Salbutamol is safe for acute wheezing in this age group 5
• MDI formulation appears safer than nebulized formulation with fewer adverse reactions 5
• No severe cardiac side effects reported in this population 5

Children under 4 years:

• Must use VHC with face mask for MDI administration 1, 2

Dosing Optimization

Higher doses may be beneficial in specific situations:

• Children with moderate-to-severe exacerbations showed greater FEV1 improvement with 0.30 mg/kg versus 0.15 mg/kg hourly dosing 6
• However, recent pediatric ICU data suggests starting continuous albuterol at 10 mg/hour provides comparable outcomes to 15 mg/hour with shorter treatment duration 7

Levalbuterol alternative:

• Administer at half the albuterol dose for equivalent efficacy and safety 1
• Children: 0.075 mg/kg (minimum 1.25 mg) every 20 minutes for 3 doses
• Adults: 1.25-2.5 mg every 20 minutes for 3 doses

Safety Monitoring

Cardiovascular Effects

• Standard doses (2.5 mg) do not significantly affect heart rate 8
• Only doses 5-10× standard (12.5-25 mg) cause clinically significant tachycardia (20-30 bpm increase) 8
• High-dose MDI therapy (7,200 mcg over 3 hours) actually showed heart rate reduction in adults with severe asthma 9
• No severe arrhythmias reported even in ICU populations or patients with cardiac comorbidity 8

When to Reassess

• Evaluate response after initial 3 doses (60-90 minutes) 1
• Response to treatment is a better predictor of hospitalization need than initial severity 1
• If previously effective regimen fails, consider need for systemic corticosteroids rather than simply increasing bronchodilator dose 3

Common Pitfalls to Avoid

1. Undertreating severe exacerbations: Don't hesitate to use continuous nebulization (0.5 mg/kg/hour in children, 10-15 mg/hour in adults) for severe cases 1

2. Withholding treatment due to tachycardia: Current evidence shows this caution is unjustified; salbutamol does not cause clinically significant arrhythmias even with underlying heart disease 8

3. Using nebulizer when MDI would suffice: MDI with spacer is equally effective and results in better outcomes for mild-to-moderate exacerbations 1, 4

4. Inadequate MDI technique: Must prime inhaler with 4 test sprays if not used for >2 weeks; clean mouthpiece weekly to prevent blockage 3

5. Forgetting ipratropium in severe exacerbations: Should add ipratropium 0.5 mg (adults) or 0.25-0.5 mg (children) every 20 minutes for 3 doses to SABA therapy in severe cases 1, 2